MedTrace Logo

Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF

NCT06208007 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-05-09

No results posted yet for this study

Summary

Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.

Conditions

Sponsors & Collaborators

  • University Medical Center Goettingen

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-23
Primary Completion
2026-01-31
Completion
2028-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06208007 on ClinicalTrials.gov